Printer Friendly

Browse Biological products industry topic

Product development subtopic

Articles

1-300 out of 600 article(s) nextnext page
Title Author Type Date Words
Janssen, Clover pushing through with Philippine trials. Jan 15, 2021 649
BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. Jan 11, 2021 219
BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. Jan 11, 2021 224
BioInvent and Cancer Research UK revise clinical development agreement for BI-1206. Jan 11, 2021 223
Indian vaccine maker denies trial 'irregularities'. Sanjay Kumar Jan 9, 2021 766
RedHill Biopharma says orphan lung disease therapy RHB-204 granted Fast Track designation by US Food and Drug Administration. Jan 8, 2021 476
FDA okays Chinese firm's vaccine clinical trials. Jan 8, 2021 263
China's Clover gets nod for Philippine trials. Jan 8, 2021 400
RedHill Biopharma says orphan lung disease therapy RHB-204 granted Fast Track designation by US Food and Drug Administration. Jan 8, 2021 474
Icon Supports Pfizer, BioNTech on the Investigational COVID-19 Vaccine Trial. Jan 5, 2021 314
RedHill Biopharma receives encouraging safety and efficacy data from Opaganib Phase 2 COVID-19 study. Clinical report Jan 4, 2021 316
RedHill Biopharma receives encouraging safety and efficacy data from Opaganib Phase 2 COVID-19 study. Clinical report Jan 4, 2021 312
China's CanSino to submit COVID-19 vaccine trial results to Mexico next week. Dec 30, 2020 221
China's CanSino to submit COVID-19 vaccine trial results to Mexico next week. Dec 30, 2020 225
Korea shows little progress in vaccine development. Dec 23, 2020 629
Transgene and BioInvent Receive CTA Approval for Phase 1/2a Trial of Oncolytic Virus BT-001 in Solid Tumors. Dec 22, 2020 561
France's Valneva to start clinical trials of its four COVID-19 vaccine candidate in UK sites. Dec 16, 2020 248
France's Valneva to start clinical trials of its four COVID-19 vaccine candidate in UK sites. Dec 16, 2020 252
Tests to start for new vaccine; CLINICAL TRIALS TO BEGIN IN NEWCASTLE. KATIE DICKINSON Reporter katie.dickinson@ncjmedia.co.uk Dec 16, 2020 333
First Subject Dosed in Phase 2 Clinical Trial for COVID-19 DNA Vaccine Candidate INO-4800 in China. Dec 11, 2020 1179
No more Philippine clinical trials for AstraZeneca. Dec 11, 2020 778
Oxford/Astra first to publish final-stage vaccine trial results. Dec 9, 2020 674
Clover Biopharmaceuticals Touts Positive Phase 1 Data for its Adjuvanted S-Trimer COVID-19 Vaccine Candidates. Dec 7, 2020 511
DOST: Trials for China's Sinovac, Clover may start end-2020 or early 2021. Nov 27, 2020 380
VBI Vaccines Touts Positive Interim Phase 1b/2a Data for Hepatitis B Immunotherapeutic in Patients with Chronic Infection. Nov 19, 2020 505
2nd vaccine 94.5% effective, trial shows. MARTIN BAGOT Nov 17, 2020 180
UK to lead final trials of vaccine. Nov 16, 2020 215
6,000 UK participants sought for final-stage Covid-19 vaccine trials. Nov 16, 2020 241
6,000 volunteers needed for final stage test of Covid vaccine; So far around 25,000 people in the UK have participated in vaccine trials. By, Neil Shaw Nov 16, 2020 636
Johnson & Johnson Seeks 6,000 UK Participants For Vaccine Trial. Nov 16, 2020 641
Medicago and GSK to begin final Covid-19 vaccine trials. Nov 13, 2020 333
Brazil allows trials of Chinese vaccine to resume. Nov 12, 2020 515
China's Sinovac denies safety issues of its COVID-19 vaccine candidate as reason for Brazil's decision to halt trials. Nov 10, 2020 217
China's Sinovac denies safety issues of its COVID-19 vaccine candidate as reason for Brazil's decision to halt trials. Nov 10, 2020 221
Brazil halts trials of Chinese Covid-19 vaccine. Nov 10, 2020 574
AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. Nov 5, 2020 277
AstraZeneca's COVID-19 vaccine deliveries on hold as it awaits trial data. Nov 5, 2020 281
Dr. Reddy's Partners On Sputnik V vaccine Clinical Trials in India. Oct 29, 2020 350
Precision NanoSystems Will Receive CDN 18.2m from the government of Canada to Develop an RNA Vaccine for COVID-19. Oct 26, 2020 299
Cyclacel Pharmaceuticals presents Phase 1 data on fadraciclib. Oct 26, 2020 330
RedHill Biopharma presents new data from Talicia Phase 3 studies. Oct 26, 2020 367
US gives full approval to antiviral remdesivir to treat Covid-19. Oct 23, 2020 542
Merck Touts Positive Topline Results from Two Additional Phase 3 Adult Studies Evaluating V114, Merck's Investigational 15-valent Pneumococcal Conjugate Vaccine. Oct 22, 2020 906
Mereo BioPharma announces FDA clearance for Phase 1b/2 study of etigilimab. Oct 19, 2020 198
'Change of mind:' China-based pharma firm will not join vaccine trials. Oct 17, 2020 305
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 161
RegeneRx Biopharmaceuticals likely to complete phase three clinical trial for dry eye syndrome in November 2020. Oct 15, 2020 165
China's Sinovac hurdles initial stage of screening for clinical trials in Philippines. Oct 15, 2020 307
Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. Oct 14, 2020 505
Johnson & Johnson second on the list of COVID-19 vaccine setbacks, markets remain calm. Oct 14, 2020 507
Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative Colitis. Oct 13, 2020 387
Gilead, Galapagos presents data from Phase 2b/3 trial of filgotinib. Oct 12, 2020 563
3 int'l COVID-19 vaccine makers gunning for Phase 3 clinical trials in PH. Oct 8, 2020 354
ARCA Biopharma announces FDA approval of IND application for AB201. Oct 7, 2020 342
IDMC recommends Can-Fite BioPharma continue Comfort trial, discontinue Acrobat. Oct 6, 2020 273
CTI BioPharma to submit NDA for potential accelerated approval of pacritinib for Myelofibrosis Patients with Severe Thrombocytopenia. Sep 30, 2020 179
CTI BioPharma to submit NDA for potential accelerated approval of pacritinib for Myelofibrosis Patients with Severe Thrombocytopenia. Sep 30, 2020 175
COVAXX begins Phase 1 clinical trial of COVID-19 vaccine UB-612 in Taiwan. Sep 29, 2020 253
COVAXX begins Phase 1 clinical trial of COVID-19 vaccine UB-612 in Taiwan. Sep 29, 2020 249
Egypt's health minister takes part in clinical trial of Chinese coronavirus vaccine candidate. Egypt Today staff Sep 28, 2020 341
India's vaccine capacity will help 'all humanity' - Modi. Sep 27, 2020 688
Clover Biopharmaceuticals Touts Positive Preclinical Data and Updates on Phase 1 Study for its Adjuvanted S-Trimer COVID-19 Vaccine Candidate. Sep 25, 2020 683
Spend 94 billion won this year to develop homegrown COVID-19 vaccine. Sep 25, 2020 296
Sinovac's Coronavac, SARS-CoV-2 Vaccine, Inactivated, Announces Approval for Phase I/II Clinical Trial in Adolescents and Children. Sep 24, 2020 307
Sinovac Starts Phase III Clinical Trials for COVID-19 Vaccine Candidate in Turkey. Sep 22, 2020 485
Seattle Genetics, Genmab Present Data from Tisotumab Vedotin innovaTV 204 Pivotal Trial in Recurrent or Metastatic Cervical Cancer at ESMO Virtual Congress 2020. Sep 21, 2020 584
Seattle Genetics, Genmab presents data from innovaTV 204 phase 2 trial. Sep 21, 2020 482
Genentech presents new data from multiple Phase III studies of Tecentriq in TNBC. Sep 20, 2020 452
Astellas Pharma, Seattle Genetics announce Padcev trial meets primary endpoint. Sep 18, 2020 216
I-MAB, MorphoSys announce FDA clearance of IND for MOR210/TJ210. Sep 17, 2020 195
Bahrain crown prince volunteers in Covid-19 vaccine trial. Arab News Sep 16, 2020 218
Phase 3 Testing: Is The Vaccine Safe? Claudia Z Sep 15, 2020 600
AstraZeneca, Oxford University Resume Covid-19 Vaccine Trials In UK. Sep 14, 2020 267
Vaxart announces FDA clearance of IND application for oral COVID-19 vaccine. Sep 14, 2020 181
7 firms sign CDA for vaccine trial candidates. Sep 10, 2020 391
AstraZeneca says COVID-19 vaccine trial paused due to unexplained illness of participant. ANI Sep 9, 2020 563
Genentech initiates Phase III clinical trial programs for fenebrutinib, Ocrevus. Sep 9, 2020 539
Sutro Biopharma reports Phase 1 data of STRO-002 in ovarian cancer. Sep 9, 2020 240
Strongbridge Biopharma announces 'positive' results from Phase 3 RECORLEV study. Clinical report Sep 8, 2020 171
Strongbridge Biopharma expects to submit RECORLEV NDA in 1Q21. Clinical report Sep 8, 2020 172
South Korea to spend W171 billion to develop COVID-19 vaccine. Sep 4, 2020 265
Florence Healthcare Supports Pfizer's COVID-19 Vaccine Clinical Trials with Extensive Connectivity Platform. Sep 3, 2020 263
Sanofi And Glaxo Aim For December Start For Phase 3 Of Vaccine Trial. Sep 3, 2020 188
TAKE YOUR BEST SHOT: The whole world wants a vaccine, but countries will naturally try to secure a supply for themselves first. Regalado, Antonio Sep 1, 2020 2302
Taiwan approves human trials for 2nd coronavirus vaccine. Aug 28, 2020 245
Scancell Holdings consortium gets government backing for Covid trial. Aug 28, 2020 283
Taiwan's 1st coronavirus vaccine on track for Phase II trials in Nov. Aug 27, 2020 343
BeiGene to develop, manufacture Singlomics anti-COVID-19 antibodies. Clinical report Aug 27, 2020 215
Mereo BioPharma initiates Phase 1b/2 trial with alvelestat in COVID-19. Aug 25, 2020 289
Matinas BioPharma publishes data from Phase 1 EnACT study of MAT2203 to treat cryptococcal meningitis. Aug 21, 2020 450
Taiwan's 1st coronavirus vaccine approved for human trials. Aug 18, 2020 327
A shot for humanity: UAE's vaccine trial for Covid-19. Reach by Gulf News Aug 14, 2020 1056
PH in talks with 16 other vaccine developers for COVID-19, not just Russia -- DOH. Aug 14, 2020 869
A shot for humanity: Join UAE's vaccine trial for Covid-19. Reach by Gulf News Aug 13, 2020 977
PH panel meets with Russian vaccine manufacturer to discuss clinical trials. Aug 12, 2020 375
DOST to meet Russian vaccine maker on possible PH participation in clinical trials. Aug 12, 2020 484
Gilead submits NDA to FDA for Veklury for COVID-19 treatment. Clinical report Aug 10, 2020 224
US conducts further clinical trial for remdesivir as COVID-19 treatment. Aug 7, 2020 525
RedHill Biopharma Phase 2/3 COVID-19 study approved in Mexico. Aug 6, 2020 220
Moderna board member steps down to avoid conflict of interest in COVID-19 clinical trial. Jul 31, 2020 188
Moderna board member steps down to avoid conflict of interest in COVID-19 clinical trial. Jul 31, 2020 192
RedHill Biopharma initiates global Phase 2/3 study for COVID-19. Jul 30, 2020 196
Genentech Shares Disappointing News on Phase III COVACTA Trial of Actemra in Hospitalized Patients with Severe COVID-19 Associated Pneumonia. Jul 29, 2020 915
Cue Biopharma begins dosing Cohort 5 in Phase 1 trial of CUE--101. Jul 28, 2020 290
Moderna's BARDA agreement expanded to support Phase 3 trial of COVID vaccine. Jul 26, 2020 386
Moderna's BARDA agreement expanded to support larger Phase 3 COVID vaccine trial. Jul 26, 2020 386
Medidata Supports Moderna's COVID-19 Vaccine Clinical Trials. Jul 23, 2020 257
RedHill Biopharma submits CTAs in Brazil, Mexico for Phase 2/3 COVID-19 program. Jul 22, 2020 344
Biogen to initiate Phase 4 study of SPINRAZA in patients treated with Zolgensma. Jul 21, 2020 377
9 Meters Biopharma doses first patients in Phase 1b/2a clinical trial in SBS. Jul 21, 2020 213
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. Jul 16, 2020 504
UAE begins world's first phase 3 trial of inactivated Covid vaccine. Jul 16, 2020 1003
RedHill Biopharma receives approval for Phase 2/3 COVID-19 study. Jul 16, 2020 350
Coronavirus: Moderna surges as coronavirus vaccine trial takes another step forward. Jul 16, 2020 502
Dynavax announces first patients dosed in Phase 1 trial of Medicago's vaccine. Jul 14, 2020 277
Genentech says Phase IIIb STASEY study data reinforces Hemlibra safety profile. Jul 13, 2020 546
Biogen initiates new phase 3 study of BAN2401 in preclinical AD. Jul 13, 2020 184
Genentech Says New Data from Phase IIIb Study Reinforces Safety Profile of Hemlibra in People with Hemophilia A. Jul 13, 2020 681
DRAP urged to take emergency steps for approving clinical trials of proposed COVID-19 vaccine. Jul 10, 2020 761
DRAP urged to take emergency steps for approving clinical trials of proposed COVID-19 vaccine. Jul 9, 2020 681
Brazil to become testing ground for coronavirus vaccine. Jul 8, 2020 732
Gilead starts Phase 1a trial of inhaled remdesivir in healthy volunteers. Jul 8, 2020 216
Sinovac COVID-19 Vaccine Collaboration with Butantan Receives Approval from Brazilian Regulator for Phase III Trial. Jul 6, 2020 827
Seattle Genetics reports 'positive' results from Phase 2 tisotumab vedotin trial. Financial report Jun 29, 2020 231
Companies Submit IND To FDA For Coronavirus Stem Cell Trial. Jun 29, 2020 397
RedHill Biopharma receives approval for COVID-19 Phase 2/3 study with opaganib. Report Jun 29, 2020 222
Stirling company to make virus vaccine; Symbiosis will supply trials. ALASTAIR MCNEILL Jun 24, 2020 420
Pfizer Starts Four Phase 3 Clinical Trials for Investigational Vaccines. Jun 23, 2020 673
Seattle Genetics Initiates Phase 1 Clinical Trials for Two Novel Antibody-Based Drug Candidates. Jun 22, 2020 523
Pfizer announces initiation of four Phase 3 investigational vaccine studies. Jun 22, 2020 153
TransCelerate Expands COVID-19 Clinical Trial Data Sharing to Include All Biopharma Companies and BioMedical Research Institutions. Jun 17, 2020 400
Cue Biopharma says enrollment remains on schedule in Phase 1 trial of CUE-101. Jun 15, 2020 452
Moderna expects to begin Phase Phase 3 study of COVID-19 vaccine in July. Jun 11, 2020 246
China's Sinovac Inks Deal with Brazil's Butantan for the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III. Jun 11, 2020 590
RedHill Biopharma submits COVID-19 CTA for Phase 2/3 study of opaganib. Clinical report Jun 10, 2020 344
PHL to join Sinovac clinical trials for Covid-19 vaccine. Jun 9, 2020 373
Chinese biopharm firm among PH's collaborators to develop COVID-19 vaccine. Jun 9, 2020 295
Baguio nurse joins WHO trials for COVID-19 treatment. Jun 6, 2020 210
Gilead, Galapagos announce Week 52 results from Phase 3 FINCH 1, FINCH 3 studies. Jun 4, 2020 153
Can-Fite BioPharma concludes meeting with EMA on Phase 3 Namodenoson development. Jun 4, 2020 253
Gilead Shows Results from Phase 3 Trial of Remdesivir in Patients with Moderate COVID-19. Jun 2, 2020 892
Gilead Sciences, Roche to study remdesivir/Actemra combination in coronavirus patients. May 29, 2020 232
Genocea presents updated long-term data from GEN-009 Phase 1/2a trial. May 29, 2020 335
Gilead Sciences, Roche to study remdesivir/Actemra combination in coronavirus patients. May 29, 2020 230
Genentech Starts Phase III Clinical Trial of Actemra Plus Remdesivir in Hospitalized Patients with Severe COVID-19 Pneumonia. May 28, 2020 1016
Genentech, Gilead initiate Phase III clinical trial of Actemra plus remdesivir. May 28, 2020 340
RedHill Biopharma aims to enroll up to 40 patients in Phase 2a study of opaganib. Clinical report May 27, 2020 184
COVID-19 vaccine clinical trials set in 2021. May 21, 2020 350
Galapagos, Gilead report Phase 2B/3 results from filgotinib study. May 20, 2020 168
Cue Biopharma to present preclinical data on CUE-102/A02, CUE-102/A24. May 18, 2020 181
Transgene and BioInvent Present Preclinical Data Demonstrating BT-001's Powerful Activity Against Solid Tumors. May 15, 2020 715
ARCA Biopharma announces presentations of Gencaro clinical data. May 7, 2020 528
RedHill Biopharma announces publication of results of Phase 3 study of Talicia. May 5, 2020 357
Moderna submits IND to FDA for Phase 2 study of coronavirus vaccine. Report Apr 27, 2020 165
LONDON MARKET EARLY CALL: Lower Call As Gilead Covid-19 Trial Fails. Apr 24, 2020 728
LONDON MARKET OPEN: UK Retail Sales And Failed Gilead Trial Hit Stocks. Apr 24, 2020 1362
Theravance Biopharma says first patient dosed in Phase 1 study of TD-0903. Report Apr 23, 2020 166
AzurRx BioPharma expects interim data from Phase 2 combination trial in Q3. Apr 21, 2020 153
RedHill Biopharma submits IND application for opaganib for COVID-19. Clinical report Apr 17, 2020 151
OncoSec Medical partnering with Providence Cancer Institute on CORVax12 trial for potential coronavirus vaccine. Apr 7, 2020 394
Geron says clinical trial activities being impacted by COVID-19 pandemic. Apr 2, 2020 250
Matinas BioPharma pauses enrollment in ongoing clinical trials. Mar 31, 2020 421
Can-Fite BioPharma implements interim analysis for Phase 3 Comfort trial. Clinical report Mar 30, 2020 201
Arbutus Biopharma says COVID-19 may impact timelines on AB-729 trials. Mar 26, 2020 201
Genentech initiates Phase III clinical trial of Actemra. Mar 19, 2020 264
Moderna reports first participant dosed in Phase 1 coronavirus vaccine study. Mar 16, 2020 322
Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19. Mar 4, 2020 639
Governments, diagnostic companies and providers respond to coronavirus outbreak. Wilson, Linda Mar 1, 2020 2007
Hansa Biopharma concludes enrollment in investigator-initiated phase 2 study in Anti-GBM patients. Jan 27, 2020 190
Hansa Biopharma concludes enrollment in investigator-initiated phase 2 study in Anti-GBM patients. Jan 27, 2020 186
Gilead Releases Disappointing Topline Results from Phase 2 ATLAS Study in Patients with Bridging Fibrosis and Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis. Clinical report Dec 19, 2019 382
Biogen Reports Top-Line Results from Phase 2 Study in Progressive Supranuclear Palsy. Dec 13, 2019 1038
New England Journal of Medicine Publishes Positive Phase III Results for Genentech's Satralizumab in Neuromyelitis Optica Spectrum Disorder. Dec 3, 2019 1026
Seattle Genetics, Astellas Forge Clinical Trial Collaboration with US Merck to Evaluate Enfortumab. Dec 3, 2019 456
Biogen Announces Enrollment Completion of Global Phase 3 Gene Therapy Study for an Inherited Retinal Disorder. Clinical report Nov 21, 2019 1368
NEC and Vaximm Forge Clinical Trial Collaboration. Nov 14, 2019 224
RedHill Biopharma Announces Publication of RHB-102 Gastroenteritis Phase 3 Study Results in JAMA. Nov 12, 2019 1710
Biogen to Host Investor Webcasts from Clinical Trials on Alzheimer's Disease (CTAD) Congress on December 5, 2019. Nov 4, 2019 621
Can-Fite BioPharma announces results from Namodenoson End-of-Phase 2 meeting. Financial report Oct 31, 2019 145
Sutro Biopharma presents data from Phase I study of STRO-002. Oct 29, 2019 261
RedHill Biopharma to present Phase 3 data on RHB-105, RHB-104. Clinical report Oct 28, 2019 122
RedHill Biopharma to Present New Phase 3 Data on RHB-105 and RHB-104 at the American College of Gastroenterology 2019 Annual Meeting. Oct 28, 2019 3169
Genentech Touts Phase III PEMPHIX Study Results Showing Rituxan Superior to Mycophenolate Mofetil in Patients With Pemphigus Vulgaris. Clinical report Oct 23, 2019 133
MorphoSys--MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China--14/10/2019. Oct 23, 2019 413
Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP. Oct 22, 2019 407
Propanc Biopharma plans to advance clinical trials on lead cancer drug PRP. Oct 22, 2019 409
MorphoSys--MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China--14/1/2019. Oct 17, 2019 413
Can-Fite BioPharma completes enrollment in Phase II NASH study of Namodenoson. Clinical report Oct 15, 2019 169
Principia Biopharma announces preliminary data of Phase 1/2 trial of PRN1008. Oct 15, 2019 276
AzurRx BioPharma announces first patients dosed in MS1819-SD clinical trial. Oct 15, 2019 160
Gilead Sciences and Galapagos NV reveal Week 52 data from the registrational Phase three FINCH 1 and FINCH 3 trials of filgotinib. Oct 14, 2019 178
Gilead Sciences and Galapagos NV reveal Week 52 data from the registrational Phase three FINCH 1 and FINCH 3 trials of filgotinib. Oct 14, 2019 174
I-Mab to expand ongoing phase II and III clinical trials of TJ202/MOR202 into China under fast-to-market development strategy. Oct 14, 2019 251
I-Mab to expand ongoing phase II and III clinical trials of TJ202/MOR202 into China under fast-to-market development strategy. Oct 14, 2019 247
MorphoSys, I-Mab Biopharma announce IND approval to initiate trials. Oct 14, 2019 197
RedHill Biopharma reports results from MAP US Phase 3 study of RHB-104. Clinical report Oct 11, 2019 477
Principia Biopharma announces preliminary data of PRN1008 from Phase 2 trial. Oct 10, 2019 441
Geron announces first patient has been dosed in IMerge Phase 3 clinical trial. Oct 10, 2019 175
Clover Biopharmaceuticals Doses First Patient in Phase I Study of SCB-313 in China for Malignant Ascites. Oct 2, 2019 362
Japan Pharmaceuticals Industry - Seattle Genetics and Astellas Announce Results from Phase 1 Trial of Investigational Agent Enfortumab Vedotin in Combination with Immune Therapy Pembrolizumab as First-Line Treatment for Advanced Bladder Cancer -- 28/9/2019. Oct 2, 2019 1246
Seattle Genetics (NASDAQ: SGEN) - Initial Results from MOUNTAINEER Trial Show Antitumor Activity of Tucatinib Combination in HER2-Positive Metastatic Colorectal Cancer -- 29/9/2019. Oct 2, 2019 405
Cue Biopharma initiates patient dosing in Phase 1 study of CUE-101. Sep 30, 2019 165
RegeneRx: Phase 3 ARISE-3 trial 'progressing smoothly' according to plan. Sep 30, 2019 333
Seattle Genetics, Astellas announce results from Phase 1 clinical trial EV-103. Sep 29, 2019 294
Seattle Genetics presents data from single arm Phase 2 MOUNTAINEER trial. Sep 29, 2019 117
AzurRx BioPharma announces results from Phase 2 trial with MS1819. Sep 25, 2019 374
Biogen to initiate DEVOTE clinical trial evaluating higher dose of SPINRAZA. Sep 18, 2019 275
Mereo BioPharma expects 12-month data from Phase 2b ASTEROID trial in Q4. Sep 17, 2019 122
Theravance Biopharma announces 'positive' results from Phase 1 trial of TD-8236. Sep 9, 2019 437
Infinity Pharmaceuticals initiates IPI-549, MARIO-3 trials. Sep 4, 2019 159
Genentech Presents Positive Phase III Study Results for One-dose Xofluza in Children with the Flu. Clinical report Sep 3, 2019 765
Nabriva Shares Volatile As Biopharma Updates FDA Filing Timeline. Chronology Aug 16, 2019 457
AzurRx BioPharma: Phase II OPTION study of MS1819-SD progressing as planned. Aug 13, 2019 155
Geron starts Phase 3 portion of IMerge to evaluate imetelstat. Aug 8, 2019 298
RegeneRx Biopharmaceuticals admits first EB patient in single-blinded, phase 2 clinical trial of candidate RGN-137. Aug 6, 2019 323
RegeneRx Biopharmaceuticals admits first EB patient in single-blinded, phase 2 clinical trial of candidate RGN-137. Aug 6, 2019 319
Arbutus Biopharma expects results from Phase 1a/1b trial of AB-506 in 1H20. Aug 5, 2019 138
TRACON, I-Mab Biopharma dose first patient in Phase 1 trial of TJD5. Aug 1, 2019 197
Dosing Begins In Phase 1/2a Study Of Treatment For Dry-AMD. Clinical report Jul 29, 2019 520
BioCardia 'validated' by biopharma giant AstraZeneca in exclusive development agreement. Jul 29, 2019 135
BioCardia 'validated' by biopharma giant AstraZeneca in exclusive development agreement. Jul 29, 2019 135
US FDA authorises Immix Biopharma to proceed with IMX-110 phase 1b/2a clinical trial expansion. Jul 24, 2019 235
US FDA authorises Immix Biopharma to proceed with IMX-110 phase 1b/2a clinical trial expansion. Jul 24, 2019 231
Theravance Biopharma presents new data from Phase 2 study of ampreloxetine. Jul 22, 2019 116
Propanc Biopharma provides update on PRP clinical trial application and reverse common stock split. Jul 16, 2019 258
Propanc Biopharma provides update on PRP clinical trial application and reverse common stock split. Jul 16, 2019 254
Propanc Biopharma Provides Update on Preparation of PRP for Clinical Trial Application Submission and Recently Completed Reverse Stock Split. Jul 16, 2019 376
Mereo BioPharma, FDA discuss design outline for Phase 2 trial of navicixizumab. Jul 15, 2019 320
Array BioPharma Inc updates results of Phase 3 BEACON CRC trial of BRAFTOVI MEKTOVI and ERBITUX in patients with advanced colorectal cancer. Jul 8, 2019 315
Array BioPharma Inc updates results of Phase 3 BEACON CRC trial of BRAFTOVI MEKTOVI and ERBITUX in patients with advanced colorectal cancer. Jul 8, 2019 311
AzurRx BioPharma begins Initiation of phase 2 clinical study for MS1819-SD. Clinical report Jul 8, 2019 155
Sinovac Biotech (NASDAQ: SVA) - Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectiou -- 16/4/2019. Jul 4, 2019 514
Bioinvent granted authorisation by US FDA to proceed with Phase I/IIa clinical trial of an immune-modulatory anti-FcI[superscript three]RllB antibody. Jul 2, 2019 219
Bioinvent granted authorisation by US FDA to proceed with Phase I/IIa clinical trial of an immune-modulatory anti-FcI[superscript three]RllB antibody. Jul 2, 2019 215
Gilead intends to submit NDA for filgotinib to FDA this year. Jul 1, 2019 116
Arbutus Biopharma receives clearance to initiate Phase 1a/1b trial of AB-729. Jun 20, 2019 137
Theravance Biopharma reports new data from Phase 2 clinical study of TD-9855. Clinical report Jun 18, 2019 125
Sutro Biopharma announces interim Phase 1 safety data for STRO-001. Jun 16, 2019 105
Genentech Touts Positive Topline Results for Gazyva in Phase II Lupus Nephritis Study. Jun 12, 2019 532
Genentech Phase II study of Gazyva met primary, key secondary endpoints. Jun 11, 2019 142
Genentech Presents Pivotal Phase III CLL14 Results for Venclexta in Combination with Gazyva for Chronic Lymphocytic Leukemia. Jun 6, 2019 115
Seattle Genetics (NASDAQ: SGEN) - Seattle Genetics Announces Additional Analyses of ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials of ADCETRIS[R] (Brentuximab Vedotin) at the 2019 ASCO Annual Meeting -- 3/6/2019. Jun 6, 2019 1242
Vaccitech begins Phase 2b clinical study of MVA-NP+M1 universal flu vaccine (VTP-100) in Belgium and concludes recruitment in Australia. Jun 5, 2019 294
Vaccitech begins Phase 2b clinical study of MVA-NP+M1 universal flu vaccine (VTP-100) in Belgium and concludes recruitment in Australia. Jun 5, 2019 290
Genentech reveals results of two phase III Xolair studies. Jun 4, 2019 194
Genentech reveals results of two phase III Xolair studies. Jun 4, 2019 190
BioInvent submits IND with US FDA for Phase I/IIa trial of anti-FcI[superscript three]RIIB antibody. Jun 3, 2019 252
BioInvent submits IND with US FDA for Phase I/IIa trial of anti-FcI[superscript three]RIIB antibody. Jun 3, 2019 248
Genentech: POLYP 1, POLYP 2 Phase III trials met co-primary, secondary endpoints. Jun 3, 2019 184
Genentech: POLYP 1, POLYP 2 Phase III trials met co-primary, secondary endpoints. Jun 3, 2019 201
Seattle Genetics, Astellas announce data from cohort of EV-201 trial. Jun 3, 2019 516
Seattle Genetics announces additional analyses of ECHELON-1, ECHELON-2 trials. Jun 3, 2019 884
Array BioPharma to present data from Phase 3 COLUMBUS trial at ASCO. May 29, 2019 155
Ansun Biopharma admits first patient with parainfluenza infection in Phase 3 Clinical Trial of DAS181. May 29, 2019 285
Ansun Biopharma admits first patient with parainfluenza infection in Phase 3 Clinical Trial of DAS181. May 29, 2019 281
Ansun Biopharma enrols first patient in phase three DAS181 clinical trial. May 29, 2019 217
Ansun Biopharma enrols first patient in phase three DAS181 clinical trial. May 29, 2019 213
Theravance Biopharma reports data from Phase 1b study of JAK inhibitor TD-1473. Report May 21, 2019 132
Array BioPharma: Phase 3 BEACON CRC trial met primary endpoints. May 21, 2019 122
Encouraging Results From OpRegen Phase 1/2a Clinical Study Presented. Clinical report May 20, 2019 316
RegeneRx enrolls first patient in RegeneRx JV phase 3 dry eye trial. May 13, 2019 191
CEL-SCI says length of Phase 3 study could be sign of Multikine's efficacy. May 8, 2019 580
Sinovac Biotech Ltd. (NASDAQ: SVA) - Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectiou -- 16/4/2019. May 8, 2019 493
RedHill Biopharma submits NDA to FDA for Talicia for H. pylori Infection. May 7, 2019 123
Sinovac Biotech Ltd. (NASDAQ: SVA) - Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectiou -- 16/4/2019. May 2, 2019 493
Forty Seven expands agreement with Genentech for third 5F9 with rituximab trial. Apr 26, 2019 146
Sinovac Biotech Ltd. (NASDAQ: SVA) - Sinovac Announces Positive Results From Phase III Trial Of a Sabin Strain-Based Inactivated Polio Vaccine (sIPV) Published in the Journal of Infectiou -- 16/4/2019. Apr 25, 2019 493
Hansa Biopharma announces receipt of Ethics and Regulatory Committee clearance to commence phase 2 Study of Imlifidase in Guillain BarrA(c) Syndrome. Apr 16, 2019 314
Hansa Biopharma announces receipt of Ethics and Regulatory Committee clearance to commence phase 2 Study of Imlifidase in Guillain BarrA(c) Syndrome. Apr 16, 2019 315
Hansa Biopharma announces receipt of Ethics and Regulatory Committee clearance to commence phase 2 Study of Imlifidase in Guillain BarrA(c) Syndrome. Apr 16, 2019 310
Hansa Biopharma Receives Ethics and Regulatory Clearance to Start Phase 2 Study of Imlifidase in Guillain BarrA(c) Syndrome. Apr 16, 2019 790
Hansa Biopharma wins Ethics and Regulatory clearance in Europe to begin Phase 2 Study of Imlifidase in Guillain BarrA(c) Syndrome. Apr 15, 2019 262
Hansa Biopharma wins Ethics and Regulatory clearance in Europe to begin Phase 2 Study of Imlifidase in Guillain BarrA(c) Syndrome. Apr 15, 2019 258
LSK BioPharma & Jiangsu Hengrui Medicine partnership wins US FDA clearance to commence Phase 3 clinical trial in advanced HCC. Apr 9, 2019 277
Gilead submits supplemental NDA for once-daily Descovy for HIV PrEP. Apr 5, 2019 353
Seattle Genetics Completes Enrollment in Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer. Apr 2, 2019 526
Seattle Genetics and Astellas Tout Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer. Apr 1, 2019 731
Seattle Genetics and Astellas announce positive top-line results from enfortumab vedotin cancer trial. Mar 29, 2019 291
Seattle Genetics and Astellas announce positive top-line results from enfortumab vedotin cancer trial. Mar 29, 2019 287
Vaxart Completes Dosing of the Lead-In Cohort in Bivalent Norovirus Vaccine Phase 1b Clinical Trial. Mar 29, 2019 373
Seattle Genetics completes enrollment in pivotal innovaTV 204 phase 2 trial. Mar 29, 2019 117
Seattle Genetics, Astellas Pharma announce topline results of EV-201 trial. Mar 28, 2019 266
Hansa Biopharma announces receipt of ethics and regulatory clearance to start phase 2 Study of imlifidase in Acute Antibody Mediated Rejection in kidney transplantation. Report Mar 27, 2019 306
Hansa Biopharma announces receipt of ethics and regulatory clearance to start phase 2 Study of imlifidase in Acute Antibody Mediated Rejection in kidney transplantation. Report Mar 27, 2019 302
Biogen, Eisai discontinue ENGAGE and EMERGE Phase 3 trials. Mar 21, 2019 252
MorphoSys--MorphoSys AG: MorphoSys Provides Updates on L-MIND and B-MIND Clinical Trials of MOR208 in Relapsed/Refractory DLBCL--7/3/2019. Mar 20, 2019 547
MorphoSys, I-Mab Biopharma initiate phase 2 study of TJ202 for multiple myeloma. Mar 19, 2019 118
Bahamas Approves Stem Cell Trial In Musculoskeletal Conditions. Mar 18, 2019 571
Bahamas Approves Stem Cell Trial In Musculoskeletal Conditions. Mar 18, 2019 571
TaiwanJ Pharmaceuticals signs JKB-122 licensing and co-development agreement with Newsoara Biopharma for Asia. Mar 11, 2019 211
TaiwanJ Pharmaceuticals signs JKB-122 licensing and co-development agreement with Newsoara Biopharma for Asia. Mar 11, 2019 207
ARCA Biopharma announces publication of BEST, HF-ACTION trial data. Mar 6, 2019 295
Principia Biopharma announces data from Phase 2 Pemphigus Vulgaris trial. Mar 3, 2019 363
Principia Biopharma presents Phase 1 PRN2246 data at ACTRIMS. Mar 1, 2019 286
AC Immune announces anti-tau monoclonal antibody entering second Phase 2 trial. Feb 20, 2019 238
ARCA Biopharma announces FDA agreement for Phase 3 PRECISION-AF trial. Feb 20, 2019 298
AzurRx BioPharma doses first patients in Phase 2 OPTION study. Feb 20, 2019 109
Gilead Sciences reveals data from the phase three Stellar-four study of selonsertib. Feb 13, 2019 226
Eiger submits lonafarnib IND with US FDA for the treatment of Hutchinson-Gilford Progeria Syndrome and progeroid laminopathies. Dec 4, 2018 287
Eiger submits lonafarnib IND with US FDA for the treatment of Hutchinson-Gilford Progeria Syndrome and progeroid laminopathies. Dec 4, 2018 283

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters